National Health Act (Pharmaceutical Benefits – Early Supply) Amendment August 2012 - specification under subsection 84AAA(2) (No. PB 56 of 2012)

Link to law: https://www.comlaw.gov.au/Details/F2012L01603

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
 
COMMONWEALTH OF AUSTRALIA
Instrument number PB 56 of 2012
National Health Act (Pharmaceutical Benefits – Early Supply) Amendment August 2012 - specification under subsection 84AAA(2)1
 
Amendment determination under subsection 84AAA(2) of the National Health Act 1953
 
I, Adriana Platona, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
 
Dated 20 July 2012
 
 
ADRIANA PLATONA
Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
 
 
 
Amendment determination — Pharmaceutical Benefits - Early Supply
 
 
1          Name of Instrument
 
(1)           This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment August 2012 - specification under subsection 84AAA(2).
 
(2)           This Instrument may also be cited as No. PB 56 of 2012.
 
2          Commencement
 
This Instrument commences on 1 August 2012.
 
 
3          Amendment of PB 30 of 2009
 
Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 - specification under subsection 84AAA(2), PB 30 of 2009.
 
Schedule 1        Amendments
[1]                       Schedule 1, entry for Auranofin
omit:
 
Auranofin
Tablet 3 mg
Oral
60
5
 
 
substitute:
 
Auranofin
Capsule 3 mg
Oral
60
5
 

Tablet 3 mg
Oral
60
5
 

 
[2]                       Schedule 1, after entry for Lercanidipine with enalapril
insert in the columns in the order indicated:
 
Letrozole
Tablet 2.5 mg
Oral
30
5
 
 
[3]                       Schedule 1, entry for Oestradiol
omit:
 
 
Transdermal patches 2 mg, 8
Transdermal
1
5
 
 
[4]                       Schedule 1, after entry for Ranitidine
insert in the columns in the order indicated:
 
Rasagiline
Tablet 1 mg (as mesilate)
Oral
30
5
 
[5]                       Schedule 1, entry for Temozolomide
omit:
 
Temozolomide
Capsule 140 mg
Oral
5
5
 
 
substitute:
 
Temozolomide
Capsule 5 mg
Oral
5
5
 

Capsule 20 mg
Oral
5
5
 

Capsule 100 mg
Oral
5
5
 

Capsule 140 mg
Oral
5
5
 

Capsule 250 mg
Oral
5
5
 

 
[6]                       Schedule 1, after entry for Theophylline
insert in the columns in the order indicated:
 
Ticagrelor
Tablet 90 mg
Oral
56
5
 
 
 
 
 
 
 
 
 
 
 
 
1Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. 
See http://www.frli.gov.au.